{
    "clinical_study": {
        "@rank": "48763", 
        "acronym": "C H R O N O S", 
        "arm_group": [
            {
                "arm_group_label": "antibiotic therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "patients are treated with a 6 week-duration of antibiotic therapy :\nRifampin IP and PO twice daily, 10mg/kg /12H\nLevofloxacin IV and PO 500-750mg once daily\nDoxycycline PO 200mg once daily\nTrimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily\nFusidic acid PO 500mg twice daily\nLinezolid IV and PO 600mg twice daily\nCiprofloxacin IV and PO 750to 1000mg/12h\nCefotaxime IV 100mg/kg in three IV infusions daily\nCeftriaxone IV,intramuscularly or subcutaneously 2g once daily\nCefepime IV ou intra-muscularly 2g /8-12h"
            }, 
            {
                "arm_group_label": "12 week-duration of antibiotic therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "patients are treated with a 12 week-duration of antibiotic therapy :\nRifampin IP and PO twice daily, 10mg/kg /12H\nLevofloxacin IV and PO 500-750mg once daily\nDoxycycline PO 200mg once daily\nTrimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily\nFusidic acid PO 500mg twice daily\nLinezolid IV and PO 600mg twice daily\nCiprofloxacin IV and PO 750to 1000mg/12h\nCefotaxime IV 100mg/kg in three IV infusions daily\nCeftriaxone IV,intramuscularly or subcutaneously 2g once daily\nCefepime IV ou intra-muscularly 2g /8-12h"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the efficacy and tolerance of 6- versus 12-week\n      antibiotic therapy in patients with diabetic foot osteomyelitis treated medically."
        }, 
        "brief_title": "Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Osteomyelitis", 
                "Diabetic Foot"
            ]
        }, 
        "detailed_description": {
            "textblock": "The aim of this randomized multicenter clinical study is to compare the efficacy and\n      tolerance of 6 versus 12-week antibiotic treatment in patients with diabetic foot\n      osteomyelitis treated medically as no equivalent data are currenty available in the\n      literature."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diabetic patients treated non-surgically (i.e. without amputation or resection of the\n             infected bone) for an osteomyelitis of the foot complicating a neuropathic foot\n             without ischemia of the foot defined as the absence of any pedal pulse. Patients aged\n             of 18 years or more were included if they had type 2 diabetes and osteomyelitis of\n             the foot (i.e.below the ankle).\n\n        Exclusion Criteria:\n\n          -  Patients with gangrene or who require bone resection or amputation when osteomyelitis\n             of the foot was diagnosed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02123628", 
            "org_study_id": "2006-00625-14"
        }, 
        "intervention": {
            "arm_group_label": [
                "antibiotic therapy", 
                "12 week-duration of antibiotic therapy"
            ], 
            "intervention_name": "duration of the antibiotic therapy", 
            "intervention_type": "Drug", 
            "other_name": [
                "- Rifampin", 
                "- Levofloxacin", 
                "- Doxycycline", 
                "- Trimethoprim- sulfamethoxazole", 
                "- Fusidic acid", 
                "- Linezolid", 
                "- Ciprofloxacin", 
                "- Cefotaxime", 
                "- Ceftriaxone", 
                "- Cefepime"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Cefotaxime", 
                "Cefoxitin", 
                "Ceftriaxone", 
                "Doxycycline", 
                "Doxycycline hyclate", 
                "Fusidic Acid", 
                "Ofloxacin", 
                "Rifampin", 
                "Cefepime", 
                "Antibiotics, Antitubercular", 
                "Linezolid", 
                "Ciprofloxacin", 
                "Sulfamethoxazole", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "diabetic foot osteomyelitis, antibiotic treatment duration", 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tourcoing", 
                    "country": "France", 
                    "state": "Nord", 
                    "zip": "59200"
                }, 
                "name": "Dron Hospital"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Six- Versus Twelve-Week Therapy for Non-Surgically-Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study", 
        "overall_official": [
            {
                "affiliation": "Dron Hospital of Tourcoing France", 
                "last_name": "Eric M Senneville, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Dron Hospital Tourcoing France", 
                "last_name": "Alina Tone, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Remission was defined as the absence of any sign of infection at the initial or a contiguous site, evaluated at least one year after the end of antibiotic treatment (ie at the end of follow-up), with neither a new infectious episode nor the need for orthopedic surgery of the foot at either of these sites during the treatment and follow-up period.", 
            "measure": "Primary outcome measure was the proportion of patients of each group with remission of diabetic foot osteomyelitis at the end of follow-up.", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02123628"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "number of episodes of adverse events attributable to the antibiotic treatment recorded in each group of patients.", 
            "measure": "tolerance to treatment in each group of patients", 
            "safety_issue": "Yes", 
            "time_frame": "6 or 12 weeks"
        }, 
        "source": "Tourcoing Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tourcoing Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}